A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05

NCT05387083 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Low Dose TP-05
DRUG: High Dose TP-05
DRUG: Placebo Comparator

Sponsor

Tarsus Pharmaceuticals, Inc.